APTENSIO XR
These highlights do not include all the information needed to use APTENSIO XR safely and effectively. See full prescribing information for APTENSIO XR. APTENSIO XR (methylphenidate hydrochloride extended-release) capsules, for oral use, CII Initial U.S. Approval: 1955
5adedc01-ebf0-11e3-ac10-0800200c9a66
HUMAN PRESCRIPTION DRUG LABEL
Oct 23, 2023
Rhodes Pharmaceuticals L.P.
DUNS: 831928986
Products 7
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
(methylphenidate hydrochloride)
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (15)
(methylphenidate hydrochloride)
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (16)
(methylphenidate hydrochloride)
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (14)
(methylphenidate hydrochloride)
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (16)
(methylphenidate hydrochloride)
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (14)
(methylphenidate hydrochloride)
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (15)
(methylphenidate hydrochloride)
Product Details
FDA regulatory identification and product classification information